Evidence map›Paper›PMID 31795203›Full record

ArticleViruses2019

IFNα and IFNγ Impede Marek's Disease Progression.

Luca D Bertzbach, Olof Harlin, Sonja Härtle, Frank Fehler, Tereza Vychodil, Benedikt B Kaufer, Bernd Kaspers

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Comprehensive analysis and validation of mBMC veterinary research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microorganisms · 2020
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Luca D BertzbachInstitute of Virology, Freie Universität Berlin, 14163 Berlin, Germany.ORCID 0000-0002-0698-5395
Olof HarlinDepartment of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
Sonja HärtleDepartment of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.ORCID 0000-0002-7957-7827
Frank FehlerLohmann Animal Health, 27472 Cuxhaven, Germany.
Tereza VychodilInstitute of Virology, Freie Universität Berlin, 14163 Berlin, Germany.
Benedikt B KauferInstitute of Virology, Freie Universität Berlin, 14163 Berlin, Germany.ORCID 0000-0003-1328-2695
Bernd KaspersDepartment of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
Freie Universität Berlin · DELudwig-Maximilians-Universität München · DELohmann Tierzucht (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marek's disease virus (MDV) is an alphaherpesvirus that causes Marek's disease, a malignant lymphoproliferative disease of domestic chickens. While MDV vaccines protect animals from clinical disease, they do not provide sterilizing immunity and allow field strains to circulate and evolve in vaccinated flocks. Therefore, there is a need for improved vaccines and for a better understanding of innate and adaptive immune responses against MDV infections. Interferons (IFNs) play important roles in the innate immune defenses against viruses and induce upregulation of a cellular antiviral state. In this report, we quantified the potent antiviral effect of IFNα and IFNγ against MDV infections in vitro. Moreover, we demonstrate that both cytokines can delay Marek's disease onset and progression in vivo. Additionally, blocking of endogenous IFNα using a specific monoclonal antibody, in turn, accelerated disease. In summary, our data reveal the effects of IFNα and IFNγ on MDV infection and improve our understanding of innate immune responses against this oncogenic virus.

Indexed as

AnimalsAntibodies, MonoclonalChickensDisease ProgressionHerpesvirus 2, GallidImmunity, InnateInterferon-alphaInterferon-gammaMarek DiseaseMarek Disease VaccinesPoultry DiseasesAntibodies, MonoclonalInterferon-alphaInterferon-gammaMarek Disease Vaccinesantitumor immune responseantiviral host defensechicken cytokinesinnate immunityMarek’s disease virusrecombinant interferons

Identifiers

PMID31795203
PMCPMC6950089
OpenAlexW2990987129

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.